|
|
||||||||
Ann Thorac Surg 1999;68:1203-1209
© 1999 The Society of Thoracic Surgeons
a University of Pittsburgh, Pittsburgh, Pennsylvania, USA
b San Francisco Heart Institute, San Francisco, California, USA
c Heart and Lung Institute of Wisconsin, Milwaukee, Wisconsin, USA
d Brigham and Womens Hospital, Boston, Massachusetts, USA
e Texas Heart Institute, Houston, Texas, USA
f Columbia-Audubon Hospital, Louisville, Kentucky, USA
g Northwestern University, Chicago, Illinois, USA
h Cedars-Sinai Medical Center, Los Angeles, California, USA
i Duke University Medical Center, Durham, North Carolina, USA
j Washington Hospital Center, Washington, DC, USA
Address reprint requests to Dr Hattler, Division of Cardiothoracic Surgery, University of Pittsburgh School of Medicine, C-700 Presbyterian University Hospital, 200 Lothrop St, Pittsburgh, PA 15213
Presented at the Thirty-fourth Annual Meeting of The Society of Thoracic Surgeons, New Orleans, LA, Jan 2628, 1998.
Background. Transmyocardial laser revascularization (TMR) provides relief for patients with chronic angina, nonamenable to direct coronary revascularization. Unmanageable, unstable angina (UUA) defines a subset of patients with refractory angina who are at high risk for myocardial infarction and death. Patients were classified in the UUA group when they had been admitted to the critical care unit with unstable angina for 7 days with three failed attempts at weaning them off intravenous antianginal medications.
Methods. Seventy-six treated patients were analyzed to determine if TMR is a viable option for patients with unmanageable unstable angina. These patients were compared with 91 routine protocol patients (protocol group [PG]) undergoing TMR for chronic angina not amenable to standard revascularization. The procedure was performed through a left thoracotomy without cardiopulmonary bypass. These patients were followed for 12 months after the TMR procedure. Both unmanageable and chronic angina patients had a high incidence of at least one prior surgical revascularization (87% and 91%, respectively).
Results. Perioperative mortality (
30 days post-TMR) was higher in the UUAG versus PG (16% vs 3%, p = 0.005). Late mortality, up to 1 year of follow-up, was similar (13% vs 11%, UUAG vs PG; p = 0.83). A majority of the adverse events in the UUAG occurred within the first 3 months post-TMR, and patients surviving this interval did well, with reduced angina of at least two classes occurring in 69%, 82%, and 82% of patients at 3, 6, and 12 months, respectively. The percent improvement in angina class from baseline was statistically significant at 3, 6, and 12 months. A comparable improvement in angina was found in the protocol group of patients.
Conclusions. TMR carried a significantly higher risk in unmanageable, unstable angina than in patients with chronic angina. In the later follow-up intervals, however, both groups demonstrated similar and persistent improvement in their angina up to 12 months after the procedure. TMR may be considered in the therapy of patients with unmanageable, unstable angina who otherwise have no recourse to effective therapy in the control of their disabling angina.
This article has been cited by other articles:
![]() |
K. A. Horvath and Y. Zhou Transmyocardial Laser Revascularization and Extravascular Angiogenetic Techniques to Increase Myocardial Blood Flow Card. Surg. Adult, January 1, 2008; 3(2008): 733 - 752. [Full Text] |
||||
![]() |
K. A. Horvath, T. B. Ferguson Jr, R. A. Guyton, and F. H. Edwards Impact of Unstable Angina on Outcomes of Transmyocardial Laser Revascularization Combined With Coronary Artery Bypass Grafting Ann. Thorac. Surg., December 1, 2005; 80(6): 2082 - 2085. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B. Leon, R. Kornowski, W. E. Downey, G. Weisz, D. S. Baim, R. O. Bonow, R. C. Hendel, D. J. Cohen, E. Gervino, R. Laham, et al. A Blinded, Randomized, Placebo-Controlled Trial of Percutaneous Laser Myocardial Revascularization to Improve Angina Symptoms in Patients With Severe Coronary Disease J. Am. Coll. Cardiol., November 15, 2005; 46(10): 1812 - 1819. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Sanni and J. Dunning Is transmyocardial revascularisation of benefit to people with 'no option' angina? Interactive CardioVascular and Thoracic Surgery, December 1, 2004; 3(4): 586 - 592. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. B. Allen, R. D. Dowling, and W. Richenbacher From controlled trials to clinical practice: monitoring transmyocardial revascularization use and outcomes J. Am. Coll. Cardiol., June 16, 2004; 43(12): 2364 - 2365. [Full Text] [PDF] |
||||
![]() |
K. B. Allen, R. D. Dowling, W. W. Angell, D. M. Gangahar, T. L. Fudge, W. Richenbacher, S. L. Selinger, M. R. Petracek, and D. Murphy Transmyocardial revascularization: 5-year follow-up of a prospective, randomized multicenter trial Ann. Thorac. Surg., April 1, 2004; 77(4): 1228 - 1234. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R. Bridges, K. A. Horvath, W. C. Nugent, D. M. Shahian, C. K. Haan, R. J. Shemin, K. B. Allen, and F. H. Edwards The Society of Thoracic Surgeons practice guideline series: transmyocardial laser revascularization Ann. Thorac. Surg., April 1, 2004; 77(4): 1494 - 1502. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Loubani, D. Chin, J. N. Leverment, and M. Galinanes Mid-term results of combined transmyocardial laser revascularization and coronary artery bypass Ann. Thorac. Surg., October 1, 2003; 76(4): 1163 - 1166. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Guleserian, H. S. Maniar, C. J. Camillo, M. S. Bailey, R. J. Damiano Jr, and M. R. Moon Quality of life and survival after transmyocardial laser revascularization with the holmium:YAG laser Ann. Thorac. Surg., June 1, 2003; 75(6): 1842 - 1848. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Saririan and M. J. Eisenberg Myocardial laser revascularization for the treatment of end-stage coronary artery disease J. Am. Coll. Cardiol., January 15, 2003; 41(2): 173 - 183. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ruel, R. A. Kelly, and F. W. Sellke Therapeutic Angiogenesis, Transmyocardial Laser Revascularization, and Cell Therapy Card. Surg. Adult, January 1, 2003; 2(2003): 715 - 750. [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |